ROBINS CHAD M

SEC Form 4 insider
CEO and Chairman · Adaptive Biotechnologies Corp ($ADPT)
1 thesis · first seen Aug 20, 2026
WindowThesesResolvedWinsWin rateAvg returnMedian return
1d111100%-0.2%-0.2%
3d1100%+2.0%+2.0%
1w1100%+2.6%+2.6%
1m000———
3m000———
6m000———
1y000———

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$ADPTSEC Form 4bearish
Sold 600,000 @ $24.80 avg · $14,882,166 · 2026-08-17

Form 4: ROBINS CHAD M sold ADPT

ROBINS CHAD M (CEO and Chairman at Adaptive Biotechnologies Corp) reported an open-market sale of 600,000 shares of ADPT at an average $24.80, roughly $14,882,166, in a Form 4 filed 2026-08-19.

At post $25.49Now $28.35+11.2% since postedas of Oct 2, 4:30 PM ET
1d-0.2%
3d+2.0%
1w+2.6%
1m+12.2%
3m—
6m—
1y—
View filing on SEC.gov →

End of results.